BioSimilar
Intas, First Indian company to launch a biosimilar product in the EU
Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreeme...
July 22, 2021 | News
Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan
Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...
June 23, 2021 | News
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...
June 10, 2021 | News
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
